返回 Agenda
Value and Access – How Do We Strike a Balance between Both?
Session Chair(s)
Indranil Bagchi, PHD, MSC
Global Head, Pricing & Market Access
GSK, United States
Value and Access – How Do We Strike a Balance between Both?
Learning Objective : Participants will understand the payer perspective on Managed Access Agreements for high cost therapies, using examples from the NHS in England
Speaker(s)
Managed Access Agreements – A New Frontier in Germany?
Evert Jan van Lente, MS
AOK Bundesverband (Federal Insurer), Germany
Director EU-Affairs
Outcome Focussed Access Agreements: Payer Perspectives
Edmund Jessop, DrMed
National Health Service, United Kingdom
Medical adviser at NHS England
Factors Leading to Difference between Regulatory and Market Access Decisions for Drugs in Six Cancers Internationally
Jan McKendrick, MSC
PRMA Consulting Ltd, United Kingdom
Senior Director